Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The fact that 2 drugs with the same chemical composition have different names, indications and list prices only underscores the complexities plan sponsors must account for when developing a GLP-1/GIP approach
Wegovy is not recommended for individuals with: A personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 Known hypersensitivity to semaglutide or any of Wegovys ingredients How soon will I see weight loss results with Wegovy
Key Features: 40 mL single-tube configuration Expanded plasma volume capacity ~10-minute single spin Designed to minimize red blood cell content Powered by validated gel-separation technology Now available from Transcend Biologics, backed by 30 years of experience in regenerative medicine
Additional safety considerations include risk of dehydration and acute kidney injury, potential worsening of diabetic retinopathy with rapid glucose improvement (particularly with semaglutide), and hypoglycemia risk when combined with insulin or sulfonylureas
